How to Become a Top Performer When You Didn’t Get Enough Training

글 내용 전체보기

FDA Issues Refusal to File Letter for Adamis’ Alternative to Cialis

글 내용 전체보기

FDA Unveils New Steps to Address the Opioid Crisis

글 내용 전체보기

Bacteriophages to the Rescue: A Possible Approach to Antibiotic Resistance

글 내용 전체보기

FDA Advisory Panel Recommends Waiting for More Data Before Approving Karyopharm’s Selinexor

글 내용 전체보기

Top 5 Biotech Companies to Emerge From Bay Area Incubators

글 내용 전체보기

Novartis and Blackstone Launch Anthos Therapeutics With $250 Million

글 내용 전체보기

Bristol-Myers Squibb Pulls 3 Programs out of CytomX Partnership

글 내용 전체보기

Gang of 7 Pharma Execs Grilled by Congress

글 내용 전체보기

Gene Therapy Market Heats up as Sarepta Buys Myonexus for $165 Million

글 내용 전체보기

CAC and rfxcel Announce a Partnership Agreement for Pharmaceutical Traceability

글 내용 전체보기

Big Pharma aces brand valuations for 2019, with Roche once again leading the way

글 내용 전체보기

Gottlieb throws FDA weight behind industry move to continuous manufacturing

글 내용 전체보기

Can Mylan amp up new launches by ramping up 2019 spending? Analysts aren’t so sure

글 내용 전체보기

PBMs send another ad message to DC lawmakers, this time on drug price negotiations

글 내용 전체보기

Takeda, Microsoft rare disease partnership publishes diagnosis road map

글 내용 전체보기

Ogilvy Health doubles down on data with internal consultancy Tripl

글 내용 전체보기

Former Novartis executive wins $1.5M in whistleblower retaliation lawsuit

글 내용 전체보기

Hand over your Humira biosim launch plans, judge tells Boehringer in AbbVie patent fight

글 내용 전체보기

Celgene CEO Alles to bag $28M if he departs after BMS merger

글 내용 전체보기

Dr. Reddy’s solid dose plant pinched by FDA for missteps

글 내용 전체보기